Rare Diseases
New treatments, research and health policy from around the world and from Türkiye. Each with its source and level of evidence.
3 updates
TürkiyeSGK and reimbursement
On April 8, 2026, a drug that prevents attacks in hereditary angioedema was added to SGK (Social Security Institution) reimbursement coverage.
TürkiyeSGK and reimbursement
On January 17, 2026, migalastat, used in Fabry disease, was added to the SGK (Social Security Institution) reimbursement list.
TürkiyeSGK and reimbursement
Minister Işıkhan announced that 54.4 billion lira was allocated for rare disease treatments in 2024.